BamSEC and AlphaSense Join Forces
Learn More

Lisata Therapeutics Inc.

NASDAQ: LSTA    
Share price (11/21/24): $2.84    
Market cap (11/21/24): $23.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-K 30 pages Material contract
12/34/56
EX-10.2
from 10-K 86 pages Material contract
12/34/56
EX-10.1
from 10-Q 8 pages Material contract
12/34/56
EX-10.25
from 10-K 4 pages Lisata Therapeutics, Inc. Clawback Policy
12/34/56
EX-10.5
from 10-K 19 pages Material contract
12/34/56
EX-10.4
from 10-K 24 pages Material contract
12/34/56
EX-10.3
from 10-K 55 pages Material contract
12/34/56
EX-10.2
from 10-K 16 pages Material contract
12/34/56
EX-10.1
from 10-K 2 pages Amended and Restated Board of Directors Compensation Policy
12/34/56
EX-10.2
from 8-K 8 pages Lisata Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.22
from S-4 8 pages Employment Agreement
12/34/56
EX-10.21
from S-4 4 pages Third Amendment to the Exclusive License Between Sanford Burnham Prebys Medical Discovery Institute and Cend Therapeutics, Inc
12/34/56
EX-10.20
from S-4 2 pages Second Amendment to the Exclusive License Between Sanford Burnham Prebys Medical Discovery Institute and Drugcendr, LLC
12/34/56
EX-10.19
from S-4 2 pages First Amendment to the Exclusive License Between Sanford Burnham Prebys Medical Discovery Institute and Drugcendr, LLC
12/34/56
EX-10.18
from S-4 20 pages Exclusive License Agreement Between Drugcendr, LLC and Sanford Burnham Prebys Medical Discovery Institute
12/34/56
EX-10.7(B)
from S-4 4 pages Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 12 pages Material contract
12/34/56
EX-10.1
from 8-K 44 pages Material contract
12/34/56
EX-10.19
from 10-K/A 21 pages Material contract
12/34/56